Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Endothelial Progenitor Cells for Chronic Ischemic Stroke
NCT02605707Phase 2Completed
- Sponsor
- Southern Medical University
- Start
- Nov 2014
- Primary completion
- Dec 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of autologous endothelial progenitor cells in ischemic stroke (2 arms), sponsored by Southern Medical University. Primary endpoint: Change from baseline in Fugl-Meyer Scale at 24 months. Started Nov 2014; status: completed.
02
Drugs
autologous endothelial progenitor cells
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02605707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605707.